Cetrelimab (anti-PDCD1) - Primary antibody, specific to PDCD1, >95%, Human IgG4SP, INHIBITOR of Programmed cell death protein 1 inhibitor, INHIBITOR of Programmed cell death protein 1 inhibitor

CAS: 2050478-92-5 Cat. No.: Ab179071
Disponível para encomenda
GRAU & PUREZA Animal Free ? Animal-free — produced without animal-derived components to reduce contamination risk. Use in biomanufacturing and culture avoiding animal-origin material. Carrier Free ? Carrier-free — supplied without added carrier protein/stabilizer. Use when carriers (e.g. BSA) would interfere with conjugation or sensitive assays. Recombinant ? Recombinant — produced via recombinant expression for defined sequence and consistency. Use for reproducible, animal-free proteins of known origin. ExactAb™ ? ExactAb™ — Aladdin's antibody line emphasizing precision and validated quality. Use for reliable, specificity-validated antibody applications. Low Endotoxin ? Low-endotoxin grade — endotoxin reduced to low controlled levels. Use in sensitive biological work where high endotoxin would interfere. Azide Free ? Azide-free — without sodium azide preservative. Use in conjugations, cell work, or assays where azide is toxic or inhibitory. Validated ? Validated grade — performance confirmed in defined applications before release. Use when you want documented assurance the reagent works as stated. ≥95%(SDS-PAGE&SEC-HPLC) See COA
Application
Animal Model, ELISA, Flow Cytometry, Functional Assay
Host species
Human
Reactive species
Cynomolgus monkey, Human
Isotype
Human IgG4SP
Conjugation
Unconjugated
★
Tamanho
Alemanha (EU)
USA*
Preço
Qtd
100μg
Ab179071-100μg
—
Em stock ≥10
79,75€
1mg
Ab179071-1mg
—
4 Em stock
496,26€
5mg
Ab179071-5mg
—
1 Em stock
1157,48€
10mg
Ab179071-10mg
Sob encomenda · 8–12 semanas
1855,14€
Enter a quantity for the sizes you want to add.

Visão geral

Cetrelimab (anti-PDCD1) is a humanized mAb targeting PD-1. Cetrelimab (anti-PDCD1) binds PD-1 (Kd=1.72 nM, HEK293) to block the interaction of PD-1 with PD-L1 and PD-L2 (IC50s=111.7 ng/mL and 138.6 ng/mL, respectively). Cetrelimab (anti-PDCD1) stimulates peripheral T cells, increases IFN-γ, IL-2, TNF-α level and inhibits tumor growth in vivo.
Purity
>95% (SDS-PAGE&SEC)
Endotoxin Level
< 1.0EU/mg

Especificações

Product Name
Cetrelimab (anti-PDCD1) - Primary antibody, specific to PDCD1, >95%, Human IgG4SP, INHIBITOR of Programmed cell death protein 1 inhibitor
Sinónimos
CD279 antibody|CD279 antigen antibody|hPD 1 antibody|hPD l antibody|hPD-1 antibody|hSLE1 antibody|PD 1 antibody|PD-1 antibody|PD1 antibody|PDCD 1 antibody|PDCD1 antibody|Programmed cell death 1 antibody|Programmed cell death 1 protein antibody|Programmed cell death protein 1 antibody|Protein PD 1 antibody|Protein PD-1 antibody|SLEB2 antibody|Systemic lupus erythematosus susceptibility 2 antibody|CD279 antigen|CD279|hPD-1|PD1|PD-1|PDCD1|programmed cell death 1|programmed cell death protein 1|Protein PD-1|SLEB2|JNJ 63723283|JNJ 3283
Especificações e pureza
Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA
Espécie hospedeira
Human
Especificidade
PDCD1
Conjugação
Unconjugated
Grau
Animal Free, Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated
Tipo de ação
INHIBITOR
Mecanismo de ação
INHIBITOR of Programmed cell death protein 1 inhibitor
Isótipo
Human IgG4SP
Tipo de corrente de luz
kappa
SDS-PAGE
26.7 kDa (Light Chain) & 53.2 kDa (Heavy Chain), under reducing conditions; 180.0 kDa, under non-reducing conditions.
Método de purificação
Protein A purified
Pureza
>95%
Concentração
See COA
CAS
2050478-92-5
Product Line
Produtos biológicos
Armazenamento e envio
Forma
Liquid
Condições de armazenamento de armazenamento
Store at -80°C,Avoid repeated freezing and thawing
Enviado em
Dry ice packs + Cold packs
Estabilidade e armazenamento
Store at -80℃ for 24 months. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle.
Imagens

Cetrelimab (anti-PDCD1) (Ab179071) - Flow Cytometry
Flow Cytometry analysis of 500 ng/mL Ionomycin (I139530) and 10 ng/mL PMA (P408905) co-stimulated MOLT-4 cells (24h) labelling PDCD1 (red) with Cetrelimab (anti-PDCD1) (Ab179071). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.


Cetrelimab (anti-PDCD1) (Ab179071) - SEC
The purity of Cetrelimab (anti-PDCD1) (Ab179071) is more than 95% verified by HPLC.

Dados avançados

Alvos associados (humanos)
PDCD1 Tclin Programmed cell death protein 1 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
PDCD1 Tclin Programmed cell death protein 1 (14 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mecanismos de ação
Certificados(CoA,COO,BSE/TSE e Mapa de Análise)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

6 results found

Lot NumberCertificate TypeDataItem
ZJ24F1114049ZJ24F1114049Certificate of AnalysisSep 08, 2026 Ab179071
ZJ24F1114050ZJ24F1114050Certificate of AnalysisSep 08, 2026 Ab179071
ZJ24F1114051ZJ24F1114051Certificate of AnalysisSep 08, 2026 Ab179071
ZJ24F0404224ZJ24F0404224Certificate of AnalysisFeb 11, 2026 Ab179071
ZJ24F0404225ZJ24F0404225Certificate of AnalysisFeb 11, 2026 Ab179071
ZJ24F0404226ZJ24F0404226Certificate of AnalysisFeb 11, 2026 Ab179071
Calculadoras de soluções
Revisões

Avaliações dos Clientes

Precisa de ajuda para escolher o grau?

O nosso guia de seleção de graus abrange pureza, estado do estabilizador e adequação à aplicação para todas as variantes do nosso catálogo.

Ver o guia de graus Animal Free → Ver o guia de graus Carrier Free → Ver o guia de graus Recombinant → Ver o guia de graus Validated → Ver o guia de graus ExactAb™ → Ver o guia de graus Low Endotoxin → Ver o guia de graus Azide Free →

Produtos Relacionados

Camrelizumab (anti-PD-1) - Primary antibody, for Flow,ELISA,Functional Assay,Kinetics (BLI),Kinetics (SPR) various applications, specific to PDCD1, >95%, Human IgG4SP, ANTAGONIST of Programmed cell death protein 1 antagonist
Cemiplimab (anti-PD-1) - Primary antibody, for ELISA,Functional Assay,Kinetics (BLI),Kinetics (SPR),Flow Cyt various applications, specific to PDCD1, >95%, Human IgG4, Antibody of programmed cell death 1 (CD279)
Nivolumab (anti-PD-1) - Primary antibody, for ELISA,Functional Assay,Flow cytometry,Kinetics (BLI),Kinetics (SPR) various applications, specific to PDCD1/PD-1/CD279, >95%, Human IgG4SP, Antibody of programmed cell death 1 (CD279)
Pembrolizumab (anti-PD-1) - Primary antibody, for ELISA,Functional Assay,Flow cytometry,Kinetics (BLI),Kinetics (SPR) various applications, specific to PDCD1, >95%, Human IgG4SP, Antibody of programmed cell death 1 (CD279)
Mouse Anti-Human IgM Antibody - Secondary antibody, for ELISA various applications, from Human, generated in Mouse, IgG1
Mouse Anti-Human IgG H&L (HRP) - Secondary antibody, for ELISA various applications, from Human, generated in Mouse, IgG1
Goat Anti-Human IgG H&L (HRP) - Secondary antibody, for WB,ELISA,IHC various applications, from Human, generated in Goat, IgG
Mouse Anti-Human IgG Antibody - Secondary antibody, for ELISA,CLIA various applications, from Human, generated in Rat, IgG1
Human IgG - Isotype Control Antibody, for WB,CLIA,LF,EIA,PRTIA various applications, generated in Human, >95%, IgG
Spartalizumab (anti-PD-1) - Primary antibody, for ELISA,Functional Assay,Kinetics (BLI),Kinetics (SPR),Flow Cyt various applications, specific to PDCD1, >95%, Human IgG4SP, Antibody of programmed cell death 1 (CD279)
Penpulimab (anti-PDCD1) - Primary antibody, for ELISA,Functional Assay,Flow cytometry,Kinetics (BLI),Kinetics (SPR) various applications, specific to PDCD1, >95%, Human IgG1, Antibody of programmed cell death 1 (CD279)
Sintilimab (anti-PD-1) - Primary antibody, >95%, Human IgG4SP, ANTAGONIST of Programmed cell death protein 1 antagonist
Dostarlimab (anti-PD-1) - Primary antibody, specific to PDCD1, >95%, Human IgG4SP, Antibody of programmed cell death 1 (CD279)
Pidilizumab (anti-PD-1) - Primary antibody, specific to PDCD1, Human IgG1, INHIBITOR of Programmed cell death protein 1 inhibitor
Retifanlimab (anti-PD-1) - Primary antibody, specific to PDCD1, >95%, Human IgG4SP, Antibody of programmed cell death 1 (CD279)
Zimberelimab (anti-PD-1) - Primary antibody, specific to PDCD1, >95%, Human IgG4SP, Antibody of programmed cell death 1 (CD279)
Tislelizumab (anti-PDCD1) - Primary antibody, specific to PDCD1, >95%, Human IgG4SP, INHIBITOR of Programmed cell death protein 1 inhibitor
Goat Anti-Human IgG Antibody - Secondary antibody, ≥ 95%
Mouse Anti-Human IgA H&L Antibody - Secondary antibody, Mouse IgG1
Goat Anti-Human IgG (HRP) - Secondary antibody
Goat Anti-Human IgG (Biotin) - Secondary antibody
PD1 Mouse mAb - Primary antibody, specific to PD1, Mouse IgG1
Goat Anti-Human IgG (Cy5) - Secondary antibody
Goat Anti-Human IgG (APC) - Secondary antibody
Goat Anti-Human IgG (PE) - Secondary antibody
Goat Anti-Human IgG (TRITC) - Secondary antibody
Goat Anti-Human IgG (FITC) - Secondary antibody
Serplulimab (anti-PDCD1) - Primary antibody, specific to PDCD1, >95%, Human IgG4SP, ANTAGONIST of Programmed cell death protein 1 antagonist
Mouse Anti-Human IgE epsilon chain Antibody - Secondary antibody
Geptanolimab (anti-PDCD1) - Primary antibody, specific to PDCD1, >95%, Human IgG4SP
Goat Anti-Human IgG Fc Antibody - Secondary antibody, Goat IgG
Budigalimab (anti-PD-1) - Primary antibody, specific to PDCD1, Human IgG1, INHIBITOR of Programmed cell death protein 1 inhibitor
Sasanlimab (anti-PD-1) - Primary antibody, specific to PDCD1, Human IgG4SP, ANTAGONIST of Programmed cell death protein 1 antagonist
Balstilimab (anti-PD-1) - Primary antibody, specific to PDCD1, Human IgG4SP-Opti, ANTAGONIST of Programmed cell death protein 1 antagonist
Pimivalimab (anti-PD-1) - Primary antibody, specific to PDCD1, >95% (SDS-PAGE&SEC), Human IgG4SP, INHIBITOR of Programmed cell death protein 1 inhibitor
Ezabenlimab (anti-PD-1) - Primary antibody, specific to PDCD1, >95% (SDS-PAGE&SEC), Human IgG4SP
Toripalimab (anti-PD-1) - Primary antibody, specific to PDCD1, Human IgG1, ANTAGONIST of Programmed cell death protein 1 antagonist
Human IgG2-Kappa - Isotype Control Antibody, Human IgG2
Human IgG3-kappa - Isotype Control Antibody, Human IgG3
Finotonlimab (anti-PD-1) - Primary antibody, specific to PDCD1, Human IgG4SP, INHIBITOR of Programmed cell death protein 1 inhibitor
PD1 Mouse mAb (FITC) - Primary antibody, specific to PD1, Mouse IgG1
PD1 Mouse mAb (PE) - Primary antibody, specific to PD1, Mouse IgG1
PD1 Mouse mAb (APC) - Primary antibody, specific to PD1, Mouse IgG1
PD1 Mouse mAb (Biotin) - Primary antibody, specific to PD1, Mouse IgG1
Peresolimab (anti-PD-1) - Primary antibody, specific to PDCD1, Human IgG1
Rosnilimab (anti-PD-1) - Primary antibody, specific to PDCD1, Human IgG1
PD1/CD279 Mouse mAb - Primary antibody, specific to PD1/CD279, Mouse IgG1
Human IgG1-kappa, anti-Spike RBD - Isotype Control Antibody, specific to Spike RBD, Human IgG1
Human IgG4-kappa - Isotype Control Antibody, IgG4
Goat Anti-Human IgG (AF647) - Secondary antibody, IgG
Goat Anti-Human IgG (AF405) - Secondary antibody, IgG
Human IgG (FITC) - Isotype Control Antibody, IgG
Human IgG (APC) - Isotype Control Antibody, IgG
Human IgG (PE) - Isotype Control Antibody, IgG
Human IgG1(P331S/E430G)-kappa, anti-HEL - Isotype Control Antibody, specific to HEL, Human IgG1(P331S/E430G)
Human IgG1(D265A/N297A)-kappa, anti-HEL - Isotype Control Antibody, specific to HEL, Human IgG1(D265A/N297A)
Human IgG1(K409R/E356D/M358L)-kappa, anti-HEL - Isotype Control Antibody, specific to HEL, Human IgG1(K409R/E356D/M358L)
Human IgG1(P329G/E356D/M358L)-kappa, anti-HEL - Isotype Control Antibody, specific to HEL, Human IgG1(P329G/E356D/M358L)
Human IgG1(F405L)-kappa, anti-HEL - Isotype Control Antibody, specific to HEL, Human IgG1(F405L)
Human IgG1(N297Q)-kappa, anti-HEL - Isotype Control Antibody, specific to HEL, Human IgG1(N297Q)
Human IgG (Biotin) - Isotype Control Antibody, IgG
Human IgG1(N297S)-kappa, anti-HEL - Isotype Control Antibody, specific to HEL, Human IgG1(N297S)
Human IgG1(E233A/L235A)-kappa, anti-HEL - Isotype Control Antibody, specific to HEL, Human IgG1(E233A/L235A)
Human IgG1(K214R/N297A)-kappa, anti-HEL - Isotype Control Antibody, specific to HEL, Human IgG1(K214R/N297A)
Human IgG1(K214R/L234A/L235A)-kappa, anti-HEL - Isotype Control Antibody, specific to HEL, Human IgG1(K214R/L234A/L235A)
Human IgG1(N297A/E356D/M358L)-kappa, anti-HEL - Isotype Control Antibody, specific to HEL, Human IgG1(N297A/E356D/M358L)
Human IgG1(L234F/L235E)-kappa, anti-HEL - Isotype Control Antibody, specific to HEL, Human IgG1(L234F/L235E)
Human IgG1(D265A)-kappa, anti-HEL - Isotype Control Antibody, specific to HEL, Human IgG1(D265A)
Human IgG1(K214R/L234F/L235E/P331S)-kappa, anti-HEL - Isotype Control Antibody, specific to HEL, Human IgG1(K214R/L234F/L235E/P331S)
Human IgG1(K214R/E356D/M358L)-kappa, anti-HEL - Isotype Control Antibody, specific to HEL, Human IgG1(K214R/E356D/M358L)
Human IgG1(L234A/L235A/G237A)-kappa, anti-HEL - Isotype Control Antibody, specific to HEL, Human IgG1(L234A/L235A/G237A)
Human IgG1(L234A/L235A/F405L)-kappa, anti-HEL - Isotype Control Antibody, specific to HEL, Human IgG1(L234A/L235A/F405L)
Human IgG1(D270N)-kappa, anti-HEL - Isotype Control Antibody, specific to HEL, Human IgG1(D270N)
Human IgG4(S228P)-kappa, anti-HEL - Isotype Control Antibody, specific to HEL, Human IgG4(S228P)
Human IgG1(N297A)-kappa, anti-HEL - Isotype Control Antibody, specific to HEL, Human IgG1(N297A)
Human IgG4(S228P/L235E/P329G)-kappa, anti-HEL - Isotype Control Antibody, specific to HEL, Human IgG4(S228P/L235E/P329G)
Human IgG1-lambda1, anti-Spike RBD - Isotype Control Antibody, specific to Spike RBD, Human IgG1
Human IgG1-lambda2, anti-Spike RBD - Isotype Control Antibody, specific to Spike RBD, Human IgG1
Iparomlimab (anti-PDCD1) - Primary antibody, specific to PDCD1, Human IgG4SP
Prolgolimab (anti-PDCD1) - Primary antibody, specific to PDCD1, Human IgG1
Nofazinlimab (anti-PDCD1) - Primary antibody, specific to PDCD1, Human IgG4SP
Rulonilimab (anti-PDCD1) - Primary antibody, specific to PDCD1, Human IgG1
Goat Anti-Human IgG (AF555) - Secondary antibody, IgG
Human IgG1-kappa (AF405), anti-Spike RBD - Isotype Control Antibody, specific to Spike RBD
Human IgG1-kappa (AF647), anti-Spike RBD - Isotype Control Antibody, specific to Spike RBD
Human IgG1-kappa (APC), anti-Spike RBD - Isotype Control Antibody, specific to Spike RBD
Human IgG1-kappa (Biotin), anti-Spike RBD - Isotype Control Antibody, specific to Spike RBD
Human IgG1-kappa (AF700), anti-Spike RBD - Isotype Control Antibody, specific to Spike RBD
Human IgG1-kappa (FITC), anti-Spike RBD - Isotype Control Antibody, specific to Spike RBD
Human IgG1-kappa (AF555), anti-Spike RBD - Isotype Control Antibody, specific to Spike RBD
Centrose patent anti-dysadherin (anti-Dysadherin) - Primary antibody, specific to FXYD5
Human IgG (AF647) - Isotype Control Antibody
Human IgG (AF488) - Isotype Control Antibody
Human IgG (AF700) - Isotype Control Antibody
Human IgG (AF405) - Isotype Control Antibody
Goat Anti-Human IgG (AF488) - Secondary antibody
Goat Anti-Human IgG Fc (Cy5) - Secondary antibody
Goat Anti-Human IgG Fc (AF555) - Secondary antibody, specific to Human IgG Fc
Goat Anti-Human IgG Fc (TRITC) - Secondary antibody
Goat Anti-Human IgG Fc (AF700) - Secondary antibody, specific to Human IgG Fc
Goat Anti-Human IgG Fc (AF405) - Secondary antibody
Goat Anti-Human IgG Fc (Biotin) - Secondary antibody, specific to Human IgG Fc
Goat Anti-Human IgG Fc (AF647) - Secondary antibody
Goat Anti-Human IgG Fc (FITC) - Secondary antibody, specific to Human IgG Fc
Human IgG (AF555) - Isotype Control Antibody

Deseja que lhe enviemos uma mensagem quando tivermos descontos disponíveis?

Lembrar-me mais tarde

Obrigado! Por favor, verifique a sua caixa de entrada de e-mail para confirmar.

Ops! As notificações estão desativadas.